Label and artwork control where nothing prints without regulatory sign-off.
V5 runs label and artwork through structured regulatory review, market-specific variants, allergen and claim verification, GS1/UDI/DSCSA serialisation and a locked chain-of-custody from approved artwork to the printed roll on the line.
What breaks without this.
Wrong label on the market
The most common cause of drug and food recalls. Because artwork lives in a design tool, approval lives in email, and printing lives on the floor.
Allergen and claim errors slip through
'Made in a facility that also processes peanuts' gets dropped in the last revision. Nobody catches it. The recall is in the news two months later.
Market variants drift
US and EU labels started from the same master. Three revisions in, they say different things about the same product.
Records-by-execution. Compliance, by design.
Structured regulatory review
Regulatory, medical, legal, brand and QA sign off on defined content zones — no free-form comment threads on a PDF.
Market and language variants from a single master
Base master + market delta model; regulatory-mandated content locked, brand elements editable, translations version-controlled.
Allergen, claim and warning verification
Rules engine cross-checks the recipe, the specification, the market's regulatory requirements and the artwork — flags omissions before proof.
GS1 / UDI / DSCSA / serialisation ready
Barcode, 2D data matrix, serialised aggregation and UDI-DI/PI generated to the correct standard for each market.
Chain-of-custody from artwork to line
Approved artwork checksum → print vendor → received roll → line scan match — no unapproved variant can be loaded to the labeller.
What to look for when you're buying.
Label errors are a leading recall cause. Criteria below distinguish real artwork control from a shared folder.
Artwork lifecycle under change control
What it tests: Are artworks controlled with versioning, review and approval?
Why it matters: Uncontrolled edits are the incident.
V5: Artwork is a first-class controlled record type.
GS1 / UDI / serialisation
What it tests: Are GS1 identifiers, UDI and serialisation formats validated?
Why it matters: Non-compliant identifiers halt distribution.
V5: GS1 and UDI validation on the artwork record; serialisation format enforced.
Translation control
What it tests: Are translations versioned per market with sign-off?
Why it matters: Multi-market label errors expand recalls.
V5: Per-market translation versioning with signed translator.
Reconciliation at print
What it tests: Is print quantity reconciled with production quantity?
Why it matters: Extra labels are contamination and diversion risk.
V5: Print reconciliation gated.
Change impact on inventory
What it tests: Do label changes trigger use-up / rework of on-hand inventory?
Why it matters: Otherwise old labels ship post-change.
V5: Change control emits use-up / rework tasks with due dates.
Spreadsheet vs legacy QMS vs V5.
Artwork approaches.
| Capability | Spreadsheet | Legacy QMS | V5 Ultimate |
|---|---|---|---|
| Artwork versioning | Shared drive | DAM | Native controlled record |
| UDI / GS1 validation | Manual | Optional | Native |
| Translation control | Emailed | Manual | Per-market versioned |
| Print reconciliation | Manual | Warehouse only | Gated at print |
The clauses, verbatim — and how V5 answers each.
Labelling clauses.
Written procedures... shall be followed. Such procedures shall incorporate the following features: (a) prevention of mislabeling...
V5: Print gating, reconciliation and issuance under control.
Medical device labelling and UDI requirements.
V5: UDI format validation and DI/PI segregation native.
Safety features on the packaging of medicinal products...
V5: Serialisation format and tamper-evidence integrated.
Step by step on the floor.
Artwork in V5.
- 1Design
Artwork drafted
Versioned; identifiers auto-validated.
- 2Approve
Regulatory & marketing sign-off
E-sig with reason.
- 3Translate
Per-market versions
Signed translator; reviewer signoff.
- 4Print
Reconciled to production
Print quantity gated by reconciliation.
- 5Change
Use-up / rework tasks
Old-stock plan emitted with due dates.
The math, with the assumptions visible.
Artwork ROI is measured in avoided recalls.
Label-driven recalls
Controls at every stage.
Change turnaround
Structured review path.
Print over-run risk
Print gated to production.
One avoided label recall usually pays multi-year subscription.
What changed on the floor.
Setting
A CPG with 24 markets and 300+ SKUs.
Before
Two label-driven recalls in three years; artwork on shared drive.
After
Zero label recalls in the following three years; per-market translation cycle down 55%.
Proof points
- Approved artwork checksum verified at the labeller — no swap
- Allergen and claim rules cross-checked against recipe + market
- GS1, UDI, DSCSA and EU FMD serialisation supported
- Recall root-cause 'wrong label' eliminated by design
Built to satisfy
- 21 CFR 201 (drug labelling)
- 21 CFR 801 (device labelling)
- 21 CFR 101 (food labelling)
- EU 1169/2011 (food information to consumers)
- DSCSA / EU FMD (drug serialisation)
- EU MDR Annex I §23 (device labelling)
Related on V5
Frequently asked questions
Does V5 integrate with Adobe Illustrator / InDesign?+
Yes — approved artwork can originate in Illustrator/InDesign; V5 owns the review, approval, checksum and chain-of-custody from that point forward.
How does V5 stop the wrong artwork loading at the labeller?+
The labeller reads a checksum from the approved artwork record; a mismatch stops the line and requires supervisor override with rationale, e-signed and audit-trailed.
Does V5 support market-specific variants without duplicating masters?+
Yes — one master + market delta. Regulatory-locked zones cannot be edited per market; brand and translation zones can. Every market's rendered artwork is derivable and versioned.
See V5 on your own line.
Free trial, no card. Live in 7 days with guided onboarding.